Gelnique Approval History
- FDA approved: Yes (First approved January 27th, 2009)
- Brand name: Gelnique
- Generic name: oxybutynin hydrochloride
- Dosage form: Topical Gel
- Previous name: OTG
- Company: Watson Pharmaceuticals, Inc.
- Treatment for: Overactive Bladder
Gelnique (oxybutynin chloride) Gel is a transdermal antispasmodic which is applied to the skin once daily for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency.
Development History and FDA Approval Process for Gelnique
|Jan 28, 2009||Watson's Gelnique (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder|
|May 28, 2008||Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing byFDA for the Treatment of Overactive Bladder|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.